Hua Shen Group proposed to raise capital 275 million

Hua Shen Group today disclosed targeted additional plans, the company intends to issue not more than 32 million shares, raise funds of 275 million yuan, for the Chinese god Group Pharmaceutical plant technology expansion and new drug development and other 4 pharmaceutical projects. The plan shows that the distribution price of this directional issue is not lower than the pricing benchmark 20 trading day 90%, that is, not less than 8.92 yuan/share.　　The company intends to raise capital of 275 million yuan, put into the technological transformation and expansion of the Chinese god Group pharmaceutical companies and new drug research and development projects, Huasheng biotechnology extension and Licatin in-depth research projects, bio-technical transformation of animal biotechnology extension projects, 37 planting base construction and reserve projects. Among them, the Hua Shen Group of Pharmaceutical Technology and research and development project total investment of 135 million yuan; The total investment of the technical renovation and Licatin in-depth research project is 65 million yuan, the annual production of Licatin 15,000, Ai Ying 2 million and reagent box 200,000 boxes; The total investment of animal bio-Technical renovation project is 45 million yuan, After completion, the production capacity of 12.4 million bottles of freeze-dried preparations will be formed, and 37 planting base project investment is 30 million yuan.